Skip to content

Palliative Care for Patients With Liver Cirrhosis

Palliative Care for Patients With Liver Cirrhosis - a Multicentre Intervention Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05431946
Acronym
LiverCare
Enrollment
200
Registered
2022-06-24
Start date
2023-08-01
Completion date
2028-08-01
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End of Life Care, Liver Cirrhosis, Nurse-Patient Relations, Quality of Life

Brief summary

Background: Patients with liver cirrhosis rarely receive palliative care although the Danish Health Authorities and WHO recommend it. The lacking palliative intervention is probably owed to a physician culture focused on life-prolonging active treatment at any cost and unclarities, and misperceptions about palliative care, which is perceived by many as exclusively for cancer patients and something that marks the end of active treatment. Study aim: Measure the effect of palliative care on the patient burden, caregiver burden, and the utilization of healthcare services. Study design: Prospective multi-center intervention study with end of study at the patients' death. We will use a 3-faceted endpoint 1) Patient burden measured by change in Hospital Anxiety and Depression Scale, 2) caregiver burden by a change in Zarit Caregiver Burden Questionnaire, and 1) health care system burden as the difference in number, length, and indication for hospital admissions and need for outpatient services. Patients: We will prospectively include 200 patients with liver cirrhosis (approx. 50 from each of 4-5 sites: Esbjerg, Herlev, Hvidovre, Århus) who have 2 or more items checked on the Supportive and Palliative Care Indicators Tool. Control groups will be identified from two non-participating hospitals and matched regarding age, gender, number of comorbidities, and alcohol and caregiver status. Methods: The intervention will be advanced care planning with conversations and actions built around a standardized symptom identification tool (EORTC QLQ-C15-PAL). Advance care planning is the collaborative process between patients and health care professionals of planning future health care. The assignment of a contact nurse to each participant is a key part of the intervention. Results: We will measure patient and caregiver burden at inclusion, after 4-6 weeks, 4-6 months, and every 6 months until the patient dies. All use of health care services will be registered. The use of health care services during the terminal 2 years will be compared that of control patients.

Interventions

BEHAVIORALAdvance Care Planning and the consequent actions

The palliative care intervention is based on the advance care planning process and the actions taken as a consequence of these conversations. The goal is the identification, assessment, and treatment of physical, psychosocial, or spiritual symptoms and problems. Advance care actions These are the actions taken to fulfill the advance care plan and can include, but are not limited to: treatments: pharmacological, psychosocial (priest, psychologist, etc.) referrals: rehabilitation, specialized palliative care team, hospice, etc. communication initiatives with relatives, primary care, public authorities

Sponsors

Herlev Hospital
CollaboratorOTHER
Aarhus University Hospital
CollaboratorOTHER
Hvidovre University Hospital
CollaboratorOTHER
Esbjerg Hospital - University Hospital of Southern Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Liver cirrhosis of any etiology (diagnosed clinically, by imaging or histological features) as predominant chronic illness 2. 2 or more items checked on the Supportive and Palliative Care Indicators Tool (SPICT™, appendix) 3. Expressed desire for palliative support from the patient and relatives 4. Ability to give informed consent

Exclusion criteria

1. Inability to give informed consent 2. Age \< 18 years 3. Ongoing contact with specialized palliative care teams or hospice 4. Other chronic life-threatening illness than liver cirrhosis is more likely to become the cause of death within 1-2 years.

Design outcomes

Primary

MeasureTime frameDescription
Intra-subject change in patient burdenFrom date of inclusion until the date of death from any cause, assessed up to 100 monthsChange in Hospital Anxiety and Depression Scale

Secondary

MeasureTime frameDescription
Intra-subject change in caregiver burdenFrom date of inclusion until the date of death from any cause, assessed up to 100 monthsChange in Zarit Caregiver Burden Questionnaire
Inter-group difference in health care system burdenFrom date of inclusion until the date of death from any cause, assessed up to 100 monthsThe difference in the use of health care services between intervention and control groups from 2 non-participating hospitals. The difference will be assessed by a review of electronic patient files and sundhed.dk.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026